Evidence map›Paper›PMID 23525583›Full record

ReviewThe Journal of membrane biology2013

Cell-specific targeting strategies for electroporation-mediated gene delivery in cells and animals.

David A Dean

Abstract readReview
In one paragraph

Review in The Journal of membrane biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Personalizing DNA Cancer Vaccines.Journal of personalized medicine · 2025
    Review
  3. Review
  4. A comprehensive comparison of DNA and RNA vaccines.Advanced drug delivery reviews · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David A DeanDepartments of Pediatrics and Biomedical Engineering, University of Rochester, 601 Elmwood Avenue, Rochester, NY, 14642, USA, david_dean@urmc.rochester.edu.

Funding

Electroporation-mediated Pulmonary Gene Transfer for Acute Lung InjuryR21HL092801 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2008 to 2012
$2.9M
Cytoplasmic trafficking of non-viral gene therapy vectorsR01EB009903 · NIBIB · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2009 to 2017
$2.7M
Alveolar Epithelial Cell-Specific Gene Therapy PlasmidsR01HL081148 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2006 to 2010
$1.8M
DNA Nuclear Import Sequences for Cell-Specific Gene and Drug DeliveryR01GM094228 · NIGMS · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2010 to 2013
$1.7M
Targeting Airway Smooth Muscle for Asthma Gene TherapyR01HL107331 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2012 to 2015
$1.5M
2012 Bioelectrochemistry Gordon Research Conference & Gordon Research SeminarR13EB015764 · NIBIB · GORDON RESEARCH CONFERENCES · PI DEAN, DAVID A · 2012 to 2012
$13k
NHLBI NIH HHS HL107331NHLBI NIH HHS HL81148NHLBI NIH HHS R01 HL081148NHLBI NIH HHS R01 HL107331NHLBI NIH HHS R21 HL092801NIBIB NIH HHS EB9903NIBIB NIH HHS R01 EB009903NIBIB NIH HHS R13 EB015764NIGMS NIH HHS R01 GM094228NIGMS NIH HHS R01GM94228
6 · The paper itself

Abstract

The use of electroporation to facilitate gene transfer is an extremely powerful and useful method for both in vitro and in vivo applications. One of its great strengths is that it induces functional destabilization and permeabilization of cell membranes throughout a tissue leading to widespread gene transfer to multiple cells and cell types within the electric field. While this is a strength, it can also be a limitation in terms of cell-specific gene delivery. The ability to restrict gene delivery and expression to particular cell types is of paramount importance for many types of gene therapy, since ectopic expression of a transgene could lead to deleterious host inflammatory responses or dysregulation of normal cellular functions. At present, there are relatively few ways to obtain cell-specific targeting of nonviral vectors, molecular probes, small molecules, and imaging agents. We have developed a novel means of restricting gene delivery to desired cell types based on the ability to control the transport of plasmids into the nuclei of desired cell types. In this article, we discuss the mechanisms of this approach and several applications in living animals to demonstrate the benefits of the combination of electroporation and selective nuclear import of plasmids for cell-specific gene delivery.

Indexed as

ElectroporationGene Transfer TechniquesAnimalsBiological TransportCell NucleusDNAGene ExpressionGenetic TherapyHumansPlasmidsTransgenesDNA

Identifiers

PMID23525583
PMCPMC3726570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.